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ABSTRACT
Background: Huang-Lian-Jie-Du-Tang (HLJDT) is the classical traditional
hinese recipe for heat clearance and detoxification and is used in diabetic patients in
he clinical practice of traditional Chinese medicine.
Objective: The aim of this study was to evaluate the protective effects of
long-term treatment with HLJDT on vascular endothelial function in rats with type
2 diabetes mellitus (T2DM).
Methods: The male T2DM model rats were induced by intraperitoneal injec-
ion of low-dose streptozotocin plus a high-fat and high-calorie laboratory diet. The
2DM animals were randomly divided into the T2DM model group, the low-dose
LJDT group (0.42 g/kg/d), and the high-dose HLJDT group (1.25 g/kg/d).
Results: Administration of HLJDT (0.42 or 1.25 g/kg/d) for 8 weeks de-
reased the levels of serum fasting blood glucose, malondialdehyde, and vascular
issue interleukin 6 but raised the level of serum superoxide dismutase compared with
he T2DM model group in a dose-dependent manner. In addition, HLJDT treatment
estored the impaired endothelial-dependent vascular relaxation in aortic preparations
rom the T2DM model group in a dose-dependent manner.
Conclusions: Early and long-term treatments with HLJDT could have
anti-inflammatory, antioxidant properties and could protect vascular endothelium
from the cardiovascular complications associated with T2DM. (Curr Ther Res Clin
Exp. 2012;73:174–185) © 2012 Elsevier HS Journals, Inc. All rights reserved.
Key words: aorta, Huang-Lian-Jie-Du-Tang, oxidative stress, type 2 diabetes
ellitus rats, vasodilation.
INTRODUCTION
The prevalence of type 2 diabetes mellitus (T2DM) is dramatically increasing
throughout the world, by 9.7% in China in 2009. There are approximately 100
Accepted for publication September 13, 2012. http://dx.doi.org/10.1016/j.curtheres.2012.09.002
© 2012 Elsevier HS Journals, Inc. All rights reserved. 0011-393X/$ - see front matter
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Q. Yi et al.million people with diabetes.1 Cardiovascular complications are currently the major
causes of morbidity and mortality in patients with T2DM.
Huang-Lian-Jie-Du-Tang (HLJDT) is a famous traditional Chinese recipe that has
been used to treat toxic heat syndromes and infectious diseases. Recently, the benefits
of HLJDT on diabetes have been noted when it was used in diabetic patients.2 Several
studies have indicated that rats with T2DM given HLJDT had reduced levels of
serum fasting blood glucose (FBG), serum fasting insulin, serum total cholesterol,
triglycerides, angiotensin II, and von Willebrand factor and increased levels of
high-density lipoproteins and nitric oxide.3 It is well-known that vascular endothelial
ell dysfunction is considered important in the progression of diabetic vascular
omplications.4 However, the effect of HLJDT on blood vessel function has not been
eported. It was also reported that endothelial injury involves inflammation and
xidative stress.5,6 An elevated level of interleukin 6 (IL-6) (a marker of inflamma-
tion) predicts the development of T2DM.7 Malondialdehyde (MDA) is the end
roduct of the major reactions leading to significant oxidation of polyunsaturated
atty acids in cellular membranes and, thus, serves as a reliable marker of oxidative
tress.8 Superoxide dismutase (SOD), an endogenous oxygen free radical scavenger,
lays a major role in oxidation and antioxidant balance. Superoxide dismutase activity
lays a vital role in the regulation of oxidative status in T2DM.9
In the present study, we investigated whether HLJDT treatment improved endo-
helial function by observing the impact of HLJDT on acetylcholine-induced endo-
helial diastolic function in the thoracic aortic ring. In rats, T2DM was induced by
high-fat diet and intraperitoneal injection of streptozotocin, and HLJDT was
dministrated for 8 weeks. We measured the levels of serum MDA, SOD, and vascular
issue IL-6 to investigate whether the protective effect of HLJDT on endothelial
unction may be due to antioxidant or anti-inflammatory pathway activation.
MATERIALS AND METHODS
Animals
All the experiments were performed in accordance with the Guidelines for the Care
nd Use of Laboratory Animals published by the US National Institutes of Health and
ere approved by the Institutional Animal Care and Use Committee of Guangzhou
edical University, Guangzhou, People’s Republic of China. Healthy male Wistar
ats (215–265 g) were purchased from Guangdong Province Medicine Experimental
nimal Center (Guangzhou, Guangdong, China) and were housed 4 to a cage with
ree access to standard rat chow and water. After 2 weeks of adaptive feeding, the rats
ere injected with streptozotocin, 30 mg/kg IP. The control rats were injected with
ehicle (0.1 M citrate buffer). Next, an oral glucose tolerance test (OGTT) was
erformed on the third day. Twenty-four rats showing abnormal OGTT results were
elected and randomly divided into 3 groups: the diabetic model group (MOD), the
ow-dose HLJDT group (0.42 g/kg/d raw herb), and the high-dose HLJDT group
1.25 g/kg/d raw herb). The HLJDT suspension was intragastrically administrated to
he rats every morning between 8:30 and 9:30, and the rats were fed a high-fat and
igh-calorie diet by adding sucrose, refined lard, milk powder, cholalic acid, and eggs
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Current Therapeutic Researchinto basic forage in the proportion of 30:20:4:2:1:63 according to the previous
report.3,10 In addition, a control group (CON) was fed a basic diet throughout the
experimental period. Except for fasting for 12 hours before the OGTT or before
humane killing of the animal, all the rats had free access to food and water. The body
weight of the animals was monitored weekly to observe the changes and adjust the
dose of drugs for administration. At the end of the 8 weeks, the animals were
humanely killed under anesthesia with pentobarbital, 45 mg/kg IP.
Drug Administration
The HLJDT was prepared by using an age-old recipe, a prescription of 4 medicinal
erbs consisting of the crude drugs Coptidis rhizoma, Scutellariae radix, Phellodendri
ortex chinensis, and Gardeniae fructus in a weight ratio of 3:2:2:3, respectively, as
escribed previously.11 Coptidis rhizoma is dry rhizome of the plant Coptis chinensis
Franch (family Ranunculaceae), Scutellariae radix is dry roots of the plant Scutellaria
baicalensis Georgi (family Labiatae), Phellodendri cortex chinensis is dry yellow bark
of the plant Phellodendron chinense Schneid (family Rutaceae), and Gardeniae fructus is
the dry ripe fruit of the plant Gardenia jasminoides Ellis (family Rubiaceae). The raw
material was provided by the First Affiliated Hospital of Guangzhou Medical Uni-
versity and was identified by associate professor Jianyie Zhang of the Pharmacy
Department of Guangzhou Medical University. All other reagents were purchased
from Sigma-Aldrich (St. Louis, Missouri), except where otherwise specified.
HPLC Analysis
The content of berberine in HLJDT was investigated by HPLC. The HPLC
nalysis was performed using a Waters 2695 liquid chromatograph (Shimadzu,
yoto, Japan) connected to a model 2998 diode array detector and controlled by LC
river Ver.2.0 for Waters Empower software. The chromatographic separation was
erformed using an Ultimate Capcell Pak C18 column (250  4.6 mm, 5-m inside
diameter; Shiseido, Japan) with a column temperature of 35°C and a UV wavelength
of 345 nm. Standard of berberine was obtained from the National Institute for
Control of Pharmaceutical and Biology Products (Beijing, China). Acetonitrile was of
HPLC grade (Merck, Darmstadt, Germany), and all other chemicals were of analytical
reagent grade. The mobile phase was composed of 2 parts: (1) 0.05 mol potassium
dihydrogen phosphate in 1 L of HPLC-grade water and (2) chromatographically pure
acetonitrile; parts 1 and 2 were mixed in the ratio of 52:48 (v/v), respectively. After
4 g of SDS was added to every 1 L of mixed solution, the pH of the solution was
adjusted to 4.0 using phosphoric acid and was degassed by helium gas. The flow rate
was set at 1 mL/min, and the injection volume was 5 L. As shown in Figure 1,
berberine was comprehensively separated, and its retention time was at 39 minutes.
The content of berberine in the HLJDT extract was 18 mg · g.
Measurement of Serum OGTT and FBG Level
The OGTT was conducted in the overnight-fasted animals by orally administering
.5 g/kg glucose (Figure 2A). Blood samples were collected from the tail vein
mmediately before (0 hours) and 1 and 2 hours after gastric perfusion. Levels of FBG
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Q. Yi et al.were measured using glucose meters and test strips (Johnson & Johnson Ltd, New
Brunswick, New Jersey). Values are presented as the average of 2 separate measure-
ments.
Measurement of Levels of Serum MDA, SOD, and Vascular
Tissue IL-6
Blood samples were collected from eyes under anesthesia by pentobarbital, 30
g/kg; serum was separated by centrifugation at 3000g for 15 minutes (Microfuge
2R; Beckman Coulter Inc, Brea, California) for the determination of MDA and SOD
evels (kits from Jiancheng Bioengineering Research Institute, Nanjing, China). The
ontent of MDA was detected by the thiobarbituric acid reagent method. The SOD
ctivity in serum was detected by the xanthine oxidase method according to the
anufacturer’s instructions. The thoracic aorta was rapidly isolated and was carefully
leaned of fat and loose connective tissue. Part of the thoracic aorta was homogenized
n the lysis buffer, and homogenates were centrifuged at 4000g for 10 minutes at 4°C.
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Figure 1. The chromatographic fingerprint of Huang-Lian-Jie-Du-Tang (HLJDT). The marked
peak of HLJDT at 39.689 minutes is (A) berberine, according to (B) the standard
berberine.he supernatant was taken for the assays of IL-6 level using an enzyme-linked
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Current Therapeutic Researchimmunosorbent assay kit (R&D Systems, Minneapolis, Minnesota) following the
manufacturer’s instructions. Protein concentration was determined by the Coomassie
Brilliant Blue method using bovine serum albumin as a standard. All the samples
were assayed in triplicate.
Evaluation of Vasorelaxant Activity in Aorta
Sections of the thoracic aorta segments were carefully sectioned into 3-mm-long
ings. Arterial rings were connected to isometric transducers (ADInstruments Inc,
olorado Springs, Colorado) and were suspended in organ chambers filled with 10 mL
f gassed (95% oxygen and 5% carbon dioxide) Krebs solution (pH 7.4, 37°C)
omposed of 118.3 mM sodium chloride, 4.7 mM potassium chloride, 2.5 mM
alcium chloride, 1.2 mM magnesium sulfate, 1.2 mM potassium dihydrogen phos-
hate, 25.0 mM sodium bicarbonate, and 11.1 mM glucose. Isometric tension was
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Figure 2. (A) Oral glucose tolerance test. CON  control group; STZ  streptozotocin-
treated group. Values are presented as mean (SEM) (n  8–24 in each group).
(B) Effects of Huang-Lian-Jie-Du-Tang (HLJDT) on serum fasting blood glucose
levels in rats with type 2 diabetes mellitus. CON  control group; HLJDTH 
high-dose HLJDT (1.25 g/kg/d); HLJDTL low-dose HLJDT (0.42 g/kg/d); MOD
type 2 diabetic model group. Values are presented as mean (SEM) (n  8 in each
group). *P < 0.05 versus CON; †P < 0.05 versus MOD.ecorded continuously. Arteries were allowed to equilibrate for 30 minutes and then
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Q. Yi et al.were gradually stretched to 2.5 g of tension over 40 minutes. After 2 challenges with
60 mM potassium chloride, 10 M indomethacin was added to eliminate the possible
nfluence of endogenous cyclooxygenase before the submaximal contractions induced
y phenylephrine (10–6 M). Vascular rings in which the maximal constrictions in
response to phenylephrine (10–6 M) did not differ significantly were selected for
elaxation experiments. After a stable contraction plateau, acetylcholine (10–9–10–4
M)-induced relaxations were conducted respectively. In another set, similar concen-
trations of sodium nitroprusside ranging from 10–9 to 10–6 M were added. The
relaxations are expressed as a percentage of maximal constriction induced by phen-
ylephrine (10–6 M).
Statistical Analysis
All the values are expressed as mean (SEM). Statistical significance was determined
y the t test for unpaired observations and the Mann-Whitney rank sum test.
ne-way ANOVA was performed for multiple comparisons between groups. In all
he comparisons, the difference was considered statistically significant at P  0.05.
RESULTS
Effects of Long-term Treatment With HLJDT on Body Weight and
FBG Level
After continuous administration of HLJDT for 8 weeks, the general condition of
he rats improved, as seen by burnished hair, increased activity, and decreased
4-hour urine volume (rats padding by day 2 times instead of 3 times a week). Body
eight increased with age. Although weight grew more slowly in the MOD group
han in the CON and HLJDT groups, there was no significant difference between
hem (data not shown). The FBG values in the MOD group were significantly higher
han those in the CON group (P  0.05). However, the FBG level was significantly
ecreased in the HLJDT group compared with the MOD group (Figure 2B).
Effects of Long-term Treatment With HLJDT on MDA Content and
SOD Activity in Serum
Serum MDA content was significantly increased and SOD activity was significantly
ecreased in the MOD group compared with the CON group (P  0.05). However,
erum MDA content was significantly reduced in the HLJDT groups compared with
he MOD group (Figure 3). In addition, the serum SOD level was significantly
ncreased in the HLJDT groups compared with the MOD group in a dose-dependent
anner (Figure 4).
Effects of Long-term Treatment With HLJDT on the IL-6 Level in
the Aorta
The vascular tissue IL-6 level was significantly increased in the MOD group
ompared with the CON group (P  0.05) but was reversed by HLJDT treatment in
dose-dependent manner (Figure 5).
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Current Therapeutic ResearchEffects of Long-term Treatment With HLJDT on Relaxation of
Aortic Rings
Acetylcholine caused a concentration-dependent relaxation of phenylephrine-pre-
ontracted aortic preparations in all the groups. Acetylcholine-induced relaxation
10–9–10–4 M) was significantly decreased in the MOD group compared with the
ON group. However, HLJDT treatment significantly increased acetylcholine-in-
uced relaxation (10–9–10–4 M) compared with that in the MOD group in a
ose-dependent manner (Figure 6). In addition, sodium nitroprusside–induced re-
axation in the aorta did not significantly differ in all the groups (data not shown).
25
20
15
10
5
0
M
D
A
 (µµ
M
)
CON MOD HLJDTL HLJDTH
†
†
*
Figure 3. Effects of Huang-Lian-Jie-Du-Tang (HLJDT) on the level of serum malondialdehyde
(MDA) in rats with type 2 diabetic mellitus. CON  control group; HLJDTH 
high-dose HLJDT (1.25 g/kg/d); HLJDTL  low-dose HLJDT (0.42 g/kg/d);
MOD  type 2 diabetic model group. Values are presented as mean (SEM) (n 
8 in each group). *P < 0.05 versus CON; †P < 0.05 versus MOD.
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Figure 4. Effects of Huang-Lian-Jie-Du-Tang (HLJDT) on the level of serum superoxide
dismutase (SOD) in rats with type 2 diabetes mellitus. CON  control group;
HLJDTH  high-dose HLJDT (1.25 g/kg/d); HLJDTL  low-dose HLJDT (0.42
g/kg/d); MOD  type 2 diabetic model group. Values are presented as mean
(SEM) (n  8 in each group). *P < 0.05 versus CON; †P < 0.05 versus MOD.
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Diabetes mellitus has become a major public health problem in the 21st century.
Taking a global perspective, T2DM accounts for 90% to 95% of all diagnosed DM
in adults,12 and strategies aimed at the prevention and treatment of diabetes are
needed. The diabetic model induced by lower-dose streptozotocin injection plus
high-fat chow feeding was recognized as T2DM due to changes in the levels of
glucose, lipids, and insulin in blood serum.10,13
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Figure 5. Effects of Huang-Lian-Jie-Du-Tang (HLJDT) on the level of interleukin 6 (IL-6) from
aorta tissue in rats with type 2 diabetes mellitus. CON  control group; HLJDTH 
high-dose HLJDT (1.25 g/kg/d); HLJDTL low-dose HLJDT (0.42 g/kg/d); MOD
type 2 diabetic model group. Values are presented as mean (SEM) (n  8 in each
group). *P < 0.05 versus CON; †P < 0.05 versus MOD.
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Figure 6. Effects of long-term administration of Huang-Lian-Jie-Du-Tang (HLJDT) on acetyl-
choline-induced relaxation in endothelium-intact thoracic aorta from rats with
type 2 diabetes mellitus. CON control group; HLJDTH high-dose HLJDT (1.25
g/kg·d); HLJDTL  low-dose HLJDT (0.42 g/kg/d); MOD  type 2 diabetic
model group. Values are presented as mean (SEM) (n  8 in each group). *P <
0.05, CON compared with MOD; †P < 0.05, HLJDT compared with MOD.
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Current Therapeutic ResearchIn this study, we established the model of T2DM (MOD). We observed that levels
f FBG, vascular tissue inflammatory cytokine IL-6, and serum MDA increased but
he level of SOD decreased in MOD. In addition, endothelium-dependent vascular
ilation mediated by acetylcholine in aortic preparations reduced in MOD. These
esults indicated that the rats developed endothelial injury, vascular inflammation,
nd oxidative stress in the large blood vessels. It is well-known that functional
lterations in the vascular endothelium occur in many diseases, including diabetes. In
he present study, we found that the acetylcholine-induced relaxation in the MOD
roup was significantly improved by long-term treatment with HLJDT in a dose-
ependent manner. The relaxation in response to sodium nitroprusside, a nitric oxide
onor, did not significantly differ between the CON and HLJDT groups. Sodium
itroprusside induced the vascular relaxation via a mechanism that does not depend
n the endothelium.14 Thus, the results suggested that the endothelium-independent
ascular dilation in the aorta was not affected by HLJDT treatment. We also found
hat MOD increased the MDA level in addition to the FBG level, decreased the SOD
evel, and increased the IL-6 level, which were reversed by HLJDT treatment,
uggesting that HLJDT had antioxidant and anti-inflammatory effects, resulting in
he improvement of MOD.
Diabetes mellitus is categorized as Xiaokezheng according to its clinical manifes-
ations in traditional Chinese medicine (TCM). Based on the theory of TCM, the main
ite of the lesion is in the lung, stomach, or kidney, and the basic pathogenesis is
ssociated with overconsumption of Yin (body fluids), causing excessive “heat” of
issues in patients with DM. Some Chinese scholars have also proposed a theory that
2DM results from “toxicity.”15 This “poison” means that there are excessive harmful
substances in the body, such as “sugar poison” (too much sugar) and too many
“inflammatory actors” and “oxygen free radicals.” The existence of poisons in the body
becomes an important factor in the long-term complications associated with T2DM.
The HLJDT is the classical TCM of heat clearance and detoxification (Arcane
Essentials from the Imperial Library). The King drug, Coptis of HLJDT, can purge
the sthenic heart-fire to eliminate the “hot poison”; the minister herb Radix Scute-
llariae can purge Shang Jiao; the adjunctive drug amur corktree bark can purge Xia
Jiao; and Fructus Gardeniae can purge the triple Jiao and reduce heat to remove the
evil heat out of the urine. These components of HLJDT can be used to enhance the
efficacy of one another according to the “differentiation treatment” of TCM. There-
fore, application of HLJDT from the poison on T2DM is also consistent with the
principles of differentiation treatment of TCM.
As is well-known, DM is characterized by elevated blood sugar levels and is often
accompanied by sustained cardiovascular complications of metabolic diseases. Mac-
rovascular and microvascular diseases are currently the principal causes of morbidity
and mortality in patients with T2DM; dysfunction of the vascular endothelial cell is
considered an initiating factor, and it plays a critical role in the development of
diabetic vascular complications.4 However, the etiology of endothelial dysfunction in
2DM is still unknown. Hyperglycemia is clearly recognized as the primary culprit
n the pathogenesis of diabetic complications. A considerable body of evidence
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important pathogenic elements in diabetic endothelial dysfunction.5–8,16
Compiled by the famous Tang dynasty doctor Wang Tao, HLJDT has been
raditionally used to treat inflammation, Chinese toxic heat syndromes, and infectious
iseases.17 Also, HLJDT is commonly prescribed in Japan for treating cerebrovascular
isease.11 It is composed of Rhizoma coptidis, Radix scutellariae, Cortex phelloden-
dri, and Fructus gardenia.11,17 Chinese medicine prescription research notes that the
ajor component of HLJDT is Rhizoma coptidis, the active ingredient of which is
erberine. In the present study, HPLC analysis also revealed that the main component
n HLJDT is berberine. Berberine, a natural plant alkaloid, is well-known for its
nti-inflammatory activity. Currently, research suggests that berberine decreases
erum lipid and glucose levels.18 Furthermore, animal experiments also show that
erberine benefits diabetes.19–25 Radix scutellariae of HLJDT is composed of a
ariety of flavonoids. The main components of flavonoids are baicalin, baicalein, and
ogonoside, which have antioxidant26 and antihyperglycemic27 properties. Cortex
hellodendri of HLJDT contains berberine, which can strengthen the role of Coptis.
he main active ingredient of Fructus gardeniae of HLJDT is geniposide. Geniposide
ncludes a variety of iridoid glycosides (also known as genipin l-glucoside), which are
herapeutic for diabetes.28 Accordingly, many ingredients in HLJDT have protective
ffects against the impairment of T2DM. The mixture of these ingredients may exert
ynergistic effects because the pharmacologic activity of HLJDT is performed by
ultilevel, multitarget, multichannel actions and the prescription plays an integrated
ole in T2DM. Moreover, there were no obvious adverse effects reported with HLJDT
ong-term clinical application.
CONCLUSIONS
The present results suggest that long-term administration of HLJDT could have
protective effects on endothelium in T2DM. The antioxidant properties coupled with
attenuation of inflammatory mediators may contribute to the protection afforded by
HLJDT. These findings indicate that HLJDT could have a positive effect on diabetic
vascular disease and could be used to prevent and treat the vascular complications of
T2DM.
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